RankAlpha logo
Back to Rankings

UFPT

UFPC
Nasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-18
View Chart
Current thesis
UFPT remains a differentiated medtech CDMO with about 92% of revenue tied to MedTech, 26 of the top 30 medical OEMs as customers, and visible capacity/program expansion in robotic surgery and safe patient handling; if 2026 ramps convert into better organic growth and margin recovery, the current price can look too low versus the packet’s median target data point.
Posture
Mixed
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -1.0.
What can break
CEO transition on June 4, 2026 could create short-term uncertainty even with planned continuity.
Momentum
73
Value
58
Sentiment
33
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $198.00 · Bull $235.00 · Bear $160.00
Data freshness
Prices
As of 2026-06-18
Fundamentals
As of 2026-06-15 • Vendor: Data Vendor v1
Scores
As of 2026-06-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-15 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-06-18
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $324.50
Why
Momentum73 · Δ7d -1.0
Value58 · Δ7d -0.1
Sentiment33 · Δ7d +7.0
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Momentum · See technicals
Momentum
73
34% active weight
Current posture
7d trendFlat
Δ7d
-1.0
Δ21d
-6.4
Value
58
32% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
-0.6
Sentiment
33
33% active weight
Current posture
7d trendImproving
Δ7d
+7.0
Δ21d
-1.2
Why this grade

Composite grade C. Momentum 73.5 / Value 58.4 / Sentiment 33.3

Fundamentals (TTM)
As of 2026-06-15
Market Cap
$1.81B
Beta
1.10
Shares Out
7.71M
P/E (TTM)
27.6
P/S (TTM)
3.06
P/FCF (TTM)
20.93
Rev YoY
+6.5%
EPS YoY
+0.0%
Gross Margin
+28.5%
Op Margin
+15.6%
Net Debt
$176.02M
Current Ratio
2.41
As of 2026-06-18 • Updated nightlySource: Internal modelMethodology